A fresh approach to tackling Alzheimer’s disease is being investigated in clinical trials in Australia. Experts say for a long time the immune system’s role in causing brain diseases such as dementia has been overlooked. "People used to think that the brain was immune privileged and it really is not," Professor Malu Tansey, a neuroscience expert at the University of Florida, said. A fresh approach to tackling Alzheimer’s disease is being investigated in clinical trials in Australia. (9News) "As we age that immune system becomes a little tired and it does not protect the nerve cells in the brain as well." Professor Tansey gave a keynote address at the Alzheimer’s Association international conference in Sydney this week. Professor Tansey is the co-inventor of a new compound that is being trialled on Alzheimer’s patients in Sydney, Melbourne, Adelaide and Perth. A new drug, called XPro1595, is designed to decrease neuroinflammation […]